NorthSea Therapeutics

NorthSea Therapeutics is a clinical-stage biotech company developing first-in-class, oral, structurally engineered lipid therapeutics. The team leverages Structurally Engineered Fatty Acid (SEFA) technology to develop novel and unique therapeutic approaches targeting metabolic, inflammatory, and fibrotic diseases. The SEFA technology has generated pipeline candidates with a broad array of inter-and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation, and fibrosis in diverse models.